RE:RE:BIOV & PAPILOCAREYes, a very genuine company. Multiple patents & patent applications, human data in >600 patients from their first generation cancer vaccine (much of it published in quality peer reviewed journals), an expandable cancer vaccine platform for other tumors (again, w/ published data), US distribution rights for the leading EU product for (HPV related) cervical lesions, university research collaborations, EU commercialization agreeements. Not a pump and dump, the team there is solid and busting their humps.